European Healthcare Acquisition & Growth Company B.V Past Earnings Performance
Past criteria checks 3/6
There is insufficient data on European Healthcare Acquisition & Growth Company B.V's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Capital Markets Industry Growth | 15.2% |
| Revenue growth rate | n/a |
| Return on equity | 237.2% |
| Net Margin | n/a |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How European Healthcare Acquisition & Growth Company B.V makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 0 | 4 | 0 | 0 |
| 31 Mar 24 | 0 | 15 | 0 | 0 |
| 31 Dec 23 | 0 | 26 | 1 | 0 |
| 30 Sep 23 | 0 | 12 | 1 | 0 |
| 30 Jun 23 | 0 | -3 | 1 | 0 |
| 31 Mar 23 | 0 | -17 | 1 | 0 |
| 31 Dec 22 | 0 | -30 | 1 | 0 |
Quality Earnings: QX0 has high quality earnings.
Growing Profit Margin: QX0 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if QX0's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: QX0 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: QX0 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Capital Markets industry (19%).
Return on Equity
High ROE: QX0's Return on Equity (237.2%) is considered outstanding.